Rx to OTC drug switches making a comeback

April 16, 2008

News

Article

Rx to OTC drug switches are forecast to increase in the coming years, according to a new study by Kalorama.

There are 14 prescription drugs that exceed $20 billion in sales in 2006 that may have the potential to reach the over-the-counter market in four years. Prescription-to-OTC switches were frequent in 2006 and 2007 and, according to a new report by

Related Content

FDA Accepts BLA Resubmission for Epidermolysis Bullosa Gene Therapy

Killian Meara

November 12th 2024

Article

The agency assigned prademagene zamikeracel a PDUFA target action date of April 29, 2025.

Looking to the Future of Independent Pharmacy

Miranda Hester

July 13th 2022

Podcast

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia

Lauren Biscaldi, MS, Managing Editor

November 5th 2024

Article

The drug is also approved to treat schizophrenia and bipolar depression.

Podcast: Pharmacy Financing With First Financial Bank

January 28th 2022

Podcast

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

FDA Expands OA REMS, Mandates Mail-Back Envelopes for Opioid Analgesics

Lauren Massaro

November 4th 2024

Article

The FDA has mandated that companies participating in the Opioid Analgesic Risk Evaluation and Mitigation Strategy program provide pre-paid mail-back envelopes for unused or expired opioid medications.